Published papers
Academic conference presentation
    （Last updated : 2026-09-15 14:49:35）
  INAKAWA Tooru
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Assistant Professor
■ Published papers
1. Other　 Effectiveness and safety of enfortumab vedotin plus pembrolizumab for patients aged 80 years and older with metastatic urothelial carcinoma: A multicenter retrospective study. 2026/08
2. Other　 Increased risk of interstitial lung disease with enfortumab vedotin plus pembrolizumab compared with sequential enfortumab vedotin in metastatic urothelial carcinoma: A multicenter retrospective study in JAPAN. 2026/05 Link
3. Original article　 Outcomes of enfortumab vedotin treatment in patients ineligible for the EV‐301 trial. 2025/09
4. Other　 Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. 2025/05 Link
■ Academic conference presentation
1. Increased risk of interstitial lung disease with enfortumab vedotin plus pembrolizumab compared with sequential enfortumab vedotin in metastatic urothelial carcinoma: A multicenter retrospective study in JAPAN. （ポスター掲示，一般） 2026/05/18
2. Real world data of enfortumab vedotin plus pembrolizumab for metastatic urothelial carcinoma: Multi-center retrospective study in Japan. （口頭，一般） 2026/04/24
3. Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. （ポスター掲示，一般） 2025/04/29
4. Surgical results of laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma at Saiseikai Kawaguchi General Hospital. （ポスター掲示，一般） 2023/04/22
5. A Clinical review of 20 with hemodialysis patients renal cell carcinomas who underwent nephrectomy at Saiseikai Kawaguchi General Hospital. （ポスター掲示，一般） 2023/04/21
Display all(6)